📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split
70%
• 50-day avg $0.09 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 0.7 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$19.86M
Shares Outstanding56.66M
Float29.40M
Cash$18.4K
Debt$1.68M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest715
Days to Cover1.0
% of FloatN/A
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Jan 31, 2020
xbrl
XBRL WARRANT
Jan 31, 2020
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RMESF
📊 RMESF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RMESF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.